-
Signature
-
Casdin Partners Master Fund, LP By: Casdin Partners GP, LLC, its General Partner By: /s/ Eli Casdin, Managing Member
-
Stock symbol
-
LAB
-
Transactions as of
-
Jan 5, 2024
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
1/9/2024, 08:51 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
LAB |
Common Stock |
Award |
|
+11.2M |
|
|
11.2M |
Jan 5, 2024 |
Direct |
F1 |
transaction |
LAB |
Common Stock |
Award |
|
+2.74M |
|
|
2.74M |
Jan 5, 2024 |
See footnote |
F2 |
holding |
LAB |
Common Stock |
|
|
|
|
|
1.2M |
Jan 5, 2024 |
See footnote |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Eli Casdin has been deputized to represent the Reporting Persons on the board of directors of the Issuer. By virtue of Mr. Casdin's representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of the Reporting Persons may be deemed directors by deputization of the Issuer. Mr. Casdin files separate Section 16 reports disclosing securities of the Issuer that he may be deemed to beneficially own for Section 16 purposes. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.